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Size conservation emerges 
spontaneously in biomolecular 
condensates formed by scaffolds 
and surfactant clients
Ignacio Sanchez‑Burgos1,2, Jerelle A. Joseph1,2,3, Rosana Collepardo‑Guevara1,2,3 & 
Jorge R. Espinosa1,2*
Biomolecular condensates are liquid‑like membraneless compartments that contribute to 
the spatiotemporal organization of proteins, RNA, and other biomolecules inside cells. Some 
membraneless compartments, such as nucleoli, are dispersed as different condensates that do not 
grow beyond a certain size, or do not present coalescence over time. In this work, using a minimal 
protein model, we show that phase separation of binary mixtures of scaffolds and low‑valency clients 
that can act as surfactants—i.e., that significantly reduce the droplet surface tension—can yield either 
a single drop or multiple droplets that conserve their sizes on long timescales (herein ‘multidroplet 
size‑conserved’ scenario’), depending on the scaffold to client ratio. Our simulations demonstrate 
that protein connectivity and condensate surface tension regulate the balance between these two 
scenarios. The multidroplet size‑conserved scenario spontaneously arises at increasing surfactant‑to‑
scaffold concentrations, when the interfacial penalty for creating small liquid droplets is sufficiently 
reduced by the surfactant proteins that are preferentially located at the interface. In contrast, low 
surfactant‑to‑scaffold concentrations enable continuous growth and fusion of droplets without 
restrictions. Overall, our work proposes one thermodynamic mechanism to help rationalize how 
size‑conserved coexisting condensates can persist inside cells—shedding light on the roles of protein 
connectivity, binding affinity, and droplet composition in this process.
To fulfill their biological functions, cells must organize their contents into different compartments. One way of 
achieving spatiotemporal organization is via the formation of membrane-bound organelles. Another, that does 
not rely on membranes, is the self-assembly of proteins and nucleic acids into biomolecular condensates through 
the process of liquid–liquid phase separation (LLPS)1–3. In LLPS, a protein solution demixes into a protein-rich 
liquid phase—the condensate—in coexistence with a protein-poor liquid matrix. Condensates are ubiquitous 
within cells, with some of the most famous examples including stress  granules4, P  granules5, nuclear  speckles6, 
and the  nucleolus7.
The interest in understanding the molecular  grammar8, 9 and biophysical determinants of cellular LLPS has 
significantly increased in recent years due, in part, to the realization that condensates take part in a wide-range 
of cellular functions—including genome  silencing10, 11,  signaling12, buffering cellular  noise13, and formation 
of super-enhancers14, among many  others15, 16. Furthermore, neurodegenerative diseases such as Alzheimer’s, 
Parkinson’s or ALS have been associated with aberrant or misregulated phase  transitions17–19.
The chief drivers of biomolecular LLPS are multivalent molecules (i.e., those possessing multiple interaction 
sites) known as ‘scaffolds’20. Scaffolds are defined as the molecules—e.g., a single type of protein, a combination 
of various cognate proteins, or mixtures of proteins and nucleic  acids21—that are able to sustain LLPS on their 
own. Above a critical concentration, scaffolds establish a sufficiently high number of transient attractive scaf-
fold–scaffold interactions per unit of volume (the ‘liquid-network connectivity’22) to compensate for the entropic 
loss upon demixing. In addition, scaffolds can establish interactions with biomolecules that are unable to phase 
separate on their own, known as ‘clients’, recruiting them to the condensates via scaffold–client interactions. The 
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recruitment of clients can alter significantly the stability and structural properties of  condensates22–24. There-
fore, together, scaffolds and clients shape the biophysical properties of the biomolecular condensates that play 
fundamental roles within the  cell25–28.
A striking observation is the presence of condensates inside cells that do not grow beyond a certain  size7, 29–31. 
Basic thermodynamics suggest that over time, LLPS should result in the formation of a single large condensate 
rather than multiple coexisting small  droplets32. The latter case is disfavored because, cummulatively, it yields 
a high surface area to volume ratio (i.e., high interfacial free energy penalty), while the former ensures that the 
interfacial free energy penalty is minimized. Despite of the thermodynamic preference for single condensates 
over multidroplet systems, both types of architectures are present within cells. Indeed, single large condensates 
have been  observed26, 33, but also diverse coexisting size-restricted droplets have been reported in different in vivo 
systems, such as in the amphibian oocyte  nucleolus7, in the Saccharomyces cerevisiae cytoplasmic processing 
 bodies34 and  elsewhere35–37. Additionally, size-conserved multidroplet architectures have been found in non-
coalescing ribonucleoprotein  condensates26 and in multiphase complex coacervates in vitro38. However, the 
underlying molecular mechanisms and biophysical driving forces behind the formation of multiple coexisting 
droplets, also known as  emulsification39, require further investigation.
Several explanations for why or how emulsions can be thermodynamically stable at biological relevant time-
scales are currently under  debate40. One possible mechanism is that the presence of active ATP-dependent 
processes might conveniently regulate the conditions where droplets grow and  coalesce41–44. Other studies sug-
gest that proteins with various highly distinct interacting domains may form micelle-like  condensates31, 45, 46. In 
multicomponent mixtures, another possibility could be that specific binding proteins act as powerful surfactants 
and, thus, reduce the droplet surface tension penalty leading to multicondensate  coexistence35, 36, 38, 47. Moreover, 
a recent alternative explanation suggests that the interplay between protein diffusion and saturation of protein 
binding sites can also induce size-conservation in  condensates29, 30. It is plausible that all these different mecha-
nisms contribute to the size conservation of condensates inside cells under different conditions.
In this work, we use a minimal protein model, which recapitulates the experimentally-observed relationship 
between protein valency and critical  parameters23, 48, 49, to investigate the regulation of droplet size in binary 
mixtures of multivalent proteins (scaffolds and clients). We show that liquid–liquid phase separation of scaffolds 
and clients mixtures, where clients act as surfactants, can give rise to single droplets or multiple size-conserved 
droplets (Fig. 1a). Further, we reveal that the transition between the two scenarios can be regulated by the con-
densate scaffold/surfactant client ratio. Our simulations suggest how general molecular features such as protein 
connectivity, binding affinity, and droplet composition can critically modulate and stabilize the formation of 
size-conserved  condensates29, 30, and might have also implications to understanding the phase behavior of mul-
tilayered  condensates23, 38, 50.
Results
A minimal protein model for scaffold and client mixtures. Coarse-grained potentials have emerged 
as powerful tools for describing the phase behavior of biomolecules, such as proteins and nucleic acids, and 
delineating the underlying physicochemical features that drive  LLPS51, 52. Various levels of molecular resolu-
tion can be achieved with coarse-grained models; encompassing mean field  descriptions53, 54, lattice-based 
 approaches55, 56, minimal  models23, 48, 49, 56–60, and sequence-dependent  representations46, 60–65. Here, we employ 
our minimal protein  model48, which has been previously applied to unveil the role of protein multivalency in 
multicomponent  condensates49 and multilayered condensate  organization66, as well as to investigate the role of 
RNA in RNA-binding protein nucleation and  stability67. In this model, proteins are described by a pseudo hard-
sphere  potential68 that accounts for their excluded volume, and by short-range potentials for modeling the differ-
ent protein binding sites, and thereby mimicking protein  multivalency48 (Fig. 1b). For computational efficiency, 
an implicit solvent is used; therefore, the condensed phase corresponds to a liquid phase, and the diluted phase 
to a vapor. In what follows, the unit of distance is σ , the molecular diameter of the proteins (both scaffolds and 
clients), and the unit of energy kBT (for further details on the model parameters and the employed reduced units 
see the “Methods” section).
Following the framework of Banani et al.20, scaffolds are defined as proteins that can establish both homotypic 
interactions and heterotypic interactions with clients, while clients (or hereafter called surfactants) as proteins 
that are limited to bind only to scaffolds (i.e., they do not bind to other clients; except where otherwise stated). 
Within this scheme, phase separation is driven by scaffolds (high-valency proteins), whereas surfactants (proteins 
with lower valency) are recruited to condensates at the expense of depleting LLPS-stabilizing scaffold–scaffold 
interactions. We model scaffolds as 4-binding sites particles and surfactants as 3-binding sites particles. (Fig. 1b). 
This choice fulfills two important requirements: (1) it ensures that scaffolds have a higher valency than the clients, 
and (2) it allows us to easily establish a common simulation temperature for the system at which each type of 
patchy particle distinctly behaves as either a scaffold or a surfactant client. The two-phase coexisting densities 
as a function of temperature for our model of scaffold proteins (blue), a 50:50 binary mixture of scaffolds and 
surfactants (black), and a system composed of just surfactants (red) are depicted in Fig. 1c (Top panel). Note that 
while in the 50:50 mixture, surfactant proteins do not interact homotypically, in the pure surfactant system they 
do; the latter allows us to compare the effect of protein valency on the critical parameters of pure self-interacting 
protein systems. These simulations show that the addition of surfactant proteins that are strong competitors for 
the scaffold binding sites significantly hinders the ability of scaffolds to phase separate (i.e., clients lower the 
critical temperature)20, 49. Moreover, the presence of surfactant clients drastically reduces the surface tension 
of the condensates (black curve) as shown in Fig. 1c (Bottom panel). In the following section, we elucidate the 
implications of the client-induced surface tension reduction on the behavior of phase-separated condensates.
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Size‑conserved condensates can be regulated by surfactant proteins. Despite their seemingly 
subordinate role in condensate formation, client molecules (e.g. low valency proteins or self-avoiding nucleic 
acids) can significantly impact the organization of biomolecular  condensates20, 38, 73, 74. Remarkable examples 
include the multilayered organization of stress  granules75, 76, the  nucleoli26, nuclear  speckles77, mixtures of RNA-
binding proteins with  RNA78, 79, and in vitro complex  coacervates38, 73, 74. While scaffolds mainly contribute to 
maximizing the condensate liquid network  connectivity20, 49, clients can severely reduce the droplet interfacial 
free energy cost of creating an  interface23. The proliferation marker protein Ki-67, a component of the mitotic 
chromosome periphery, is an important example of a natural surfactant in intracellular  compartmentalization35. 
In this context, our simulations show that low-valency clients that do not establish homotypic interactions 
behave as surfactants within condensates, as they can greatly decrease the condensate surface tension [Fig. 1c 
(Bottom)].
To further investigate the role of surfactant clients, we perform two sets of Direct Coexistence (DC) 
 simulations68–71: (1) for the pure scaffold system, and (2) for the 50:50 binary mixture of scaffold and surfactants 
shown in Fig. 1c. At a constant temperature of T∗/T∗c = 0.75 and a global (system) density of ρ∗ = 0.136 (both 
in reduced units; see “Methods” section for further details on the employed reduced magnitudes), we create 
three different simulation box geometries with the dimensions summarized in Table 1. Using this approach, we 
can effectively modulate the surface/volume ratio of the condensed phase (hereafter called droplet): where the 
droplet surface is S = 2 ∗ Ly ∗ Lz and its volume is V = Ly ∗ Lz ∗ Lx,slab ; with Lx,slab representing the width of 
the condensate in the x direction, and Lx , Ly and Lz  being the different sides of the simulation box. Figure 2a–c, 
summarizes the phase behavior of the pure scaffold system (Top panels) and the 50:50 binary mixture (Mid-
dle panels) along the three designed simulation box geometries. The pure scaffold condensate exhibits distinct 
surface/volume ratios depending on the box geometry (see Table 1), while maintaining the same droplet density 
on all three cases. In other words, the scaffold condensate would be able to continuously grow as a single droplet 
at expense of the diluted phase until reaching equilibrium. In contrast, the scaffold–surfactant mixture yields 
various coexisting equilibrium droplets with a roughly constant surface/volume ratio of 0.21(2) σ−1 in all systems 
Figure 1.  (a) Schematic representation of single-droplet formation versus size-conserved protein condensation. 
Scaffold proteins are depicted as blue spheres, while surfactant clients are shown as red spheres. (b) Minimal 
coarse-grained model for protein LLPS: Blue and red spheres represent the excluded volume of scaffold and 
surfactant (client) proteins respectively, while gray patches represent the binding sites of the proteins. Two 
different proteins are modeled: scaffold proteins, with 4 promiscuous binding sites in a tetrahedral arrangement, 
and surfactant proteins, with 3 binding sites in a planar equidistant arrangement that can only bind to scaffold 
binding sites (except where otherwise stated). Details on the model parameters are provided in the “Methods” 
section. (c) Top: Phase diagram in the temperature–density plane for a scaffold protein system (blue), a 50:50 
scaffold–surfactant mixture (black) and for a hypothetical surfactant system in which client proteins can 
self-interact (red). The same self-interacting potential employed for scaffold proteins (blue) is also applied for 
surfactant proteins that can hypothetically self-interact (red). This system serves to further illustrate the effect 
of multivalency in LLPS. Filled circles indicate the estimated coexisting densities from Direct Coexistence 
 simulations68–71, and empty ones depict the critical points calculated via the law of rectilinear diameters and 
critical  exponents72 (see Supporting Information for details on these calculations). Bottom: Surface tension 
( γ ) dependence on temperature for the scaffold system (blue), the 50:50 scaffold–surfactant mixture (black), 
and the hypothetical system in which surfactant proteins can self interact (red). Filled squares represent direct 
estimations of γ , continuous curves depict fits to our data of the following form: γ ∝ (T∗ − T∗c )1.26 , and empty 
squares show the critical temperature of each system evaluated through the law of rectilinear diameters and 
critical  exponents72. The vertical dashed line indicates the temperature at which the remainder of our study is 
performed. Note that temperature (in reduced units, T∗ ) is renormalized by the critical temperature T∗c  (also in 
reduced units) of the scaffold protein system ( T∗c = 0.12).
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(Table 1). This result strongly suggests how size-conserved multidroplet phase behavior can be simply induced 
by the presence of low valency clients, which actively contribute to lowering the surface tension of the droplets 
[Fig. 1c (Bottom)]—thereby serving as natural  surfactants35, 36.
We next analyze the composition of the different coexisting scaffold–surfactant condensates along the distinct 
box geometries [Fig. 2 (Bottom panels)]. In all cases, including the pure scaffold condensate, the properties of the 
droplets are remarkably similar; i.e., the density of all droplets, as well as their composition and surface tension 
are roughly constant (Table 2). Notably, we find that the surfactant density profile becomes higher than that of 
scaffolds at the droplet interface, showing how the partition coefficient of surfactants is greater than that of scaf-
folds in the outer region. Previous works suggest that accumulation of surfactants at the interface is preferable 
as it minimizes the condensate surface  tension35, 38, 66. We also verify that the presence of multiple coexisting 
droplets is the thermodynamically stable state, rather than just metastable, by simulating over sufficiently long 
timescales to allow for multiple droplet fusion events and variations in droplet composition. Importantly, these 
tests reveal that even when in contact the droplets coexist without coalescing or altering their equilibrium com-
position. The multidroplet behavior of size-conserved condensates (in our case of ∼ 0.21 σ−1 surface/volume 
ratio) is a consequence of the thermodynamic conditions of our system (i.e., mixture composition, temperature, 
and density). Note that droplet curvature effects such as Laplace internal  pressure80 or surface tension depend-
ence on droplet  curvature81 have not been considered in our simulations, since we do not expect them to play 
an important role at biologically relevant droplet size scales ( O µm)40. Those effects are only expected to be 
dominant in the nanometer scale (i.e., up to droplet radii of tens of nanometers)81–84.
The presence of surfactant clients within the condensate substantially lowers the liquid network  connectivity49, 
85, 86 and, therefore, reduces the enthalpic gain sustaining LLPS. Consequently, the system minimizes its free 
energy by optimizing the number of surfactants that are incorporated into the condensed phase; i.e., by creat-
ing higher surface/volume ratios, where surfactants are preferentially located towards the interface rather than 
in the core. Such free energy optimization yields multiple coexisting condensates of a certain size, rather than 
a single-condensate system. Moreover, the emergence of multiple coexisting droplets stabilised by surfactant 
Table 1.  Simulation box dimensions and condensate surface/volume ratios (S/V) of the three box geometries 
represented in Fig. 2 for the pure scaffold system and the 50:50 binary mixture of scaffold and surfactant 
proteins. Geometries (a), (b) and (c) account for the (a), (b) and (c) panels shown in Fig. 2, respectively.
Box geometry (a) (b) (c)
Lx/σ 43.7 68.1 124.8
(Ly = Lz)/σ 17.5 13.7 10.3
Scaffold S/V ratio / σ−1 0.14(2) 0.12(2) 0.09(2)
50:50 mixture S/V ratio / σ−1 0.21(2) 0.21(2) 0.20(2)
Figure 2.  Direct Coexistence simulations for a scaffold protein system (Top panels) and a 50:50 binary mixture 
of scaffold and surfactant proteins (Middle panels) with different simulation box geometries (see Table 1 
for the different simulation box sides employed in a, b and c geometries). All simulations were performed 
at T∗/T∗c = 0.75 and a global density of ρ∗ = 0.136 . (a)–(c) (Top and Middle panels): Scaffold proteins are 
colored in blue and surfactant clients in red; the protein binding sites of both protein types are colored in 
gray. (a)–(c) (Bottom panels): Density profiles along the long side (x) of each simulation box  Lx for the 50:50 
scaffold–surfactant mixture. The (scaffold+surfactant) total density profile is depicted in black, the surfactant 
client density profile is shown in red, and that of scaffolds in blue. Densities of the different scaffold–surfactant 
coexisting droplets, as well as the scaffold molar fraction in the condensed and diluted phase, for each geometry 
are given in Table 2. The density of the pure scaffold condensates in all geometries is 0.54(1).
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proteins instead of a single condensate can also contribute to increase the entropy of the system, and thus, 
lowering its free energy. Nonetheless, this behavior is only thermodynamically favorable when the condensate 
surface tension is very low, as in the case of the 50:50 scaffold–surfactant condensates with a surface tension of 
γ = 0.23 kBT σ
−2—almost 7 times lower than that of the pure scaffold condensate ( γ = 1.58 kBT σ−2 ) at the 
same conditions ( T∗/T∗c = 0.75).
Surfactant concentration critically modulates droplet size. As discussed in the previous section, 
our minimal protein model shows that for a given composition of scaffold and surfactant clients, independent 
of the imposed box geometry, droplets can only grow to a certain size. This size-restricted growth is, in turn, 
determined by the optimal surface/volume ratio that minimizes the free energy of the coexisting liquid phases. 
Therefore, larger system sizes lead to higher number of coexisting size-conserved droplets. On the other hand, 
when the condensate is only composed of scaffold proteins, as the system size increases, the size of the conden-
sate simply grows instead of yielding new multiple size-conserved droplets (Fig. 2). These results illustrate how a 
simple model for scaffold and surfactant proteins, merely controlled by protein valency and binding affinity, can 
recapitulate mesoscale features of in vivo and in vitro condensates that exhibit size-conserved  growth7, 26, 34–38. 
Since this phase behavior only arises when the concentration of surfactants is not negligible, we now investigate 
how condensates can switch between both scenarios, and how their surface/volume ratio is modulated by their 
relative scaffold–surfactant composition.
By gradually increasing the surfactant client concentration of the scaffold–surfactant mixture (at a constant 
temperature and system density), the condensate size progressively decreases to accommodate the equilib-
rium droplet surface/volume ratio to the simulation box geometry; i.e., the condensate splits into two and, 
subsequently, into three coexisting liquid droplets (see Fig. 3). We note that the composition of the different 
coexisting droplets at a given surfactant concentration is remarkably similar, highlighting that all droplets are 
in equilibrium. In parallel, we evaluate the surface tension of the different coexisting droplets as a function of 
surfactant concentration. We find that γ monotonically decreases (but not linearly) as the surfactant concentra-
tion increases (Fig. 3). This result is not surprising (see Fig. 1c) given that one of the key molecular driving forces 
behind size-conserved multidroplet formation is the reduction of γ by surfactants coating the droplet surface. 
Above a certain surfactant concentration—exceeding 65 % for our system and at the given conditions—LLPS is 
inhibited. Beyond this limit, the condensate liquid network connectivity sustained by scaffold proteins can no 
longer compensate the mixing entropy of the system. We also analyze the surface/volume ratio of the droplets 
as a function of surfactant concentration. At infinitely low surfactant concentration, the condensate displays a 
ratio of ∼ 0.09 σ−1 . However, such a ratio is fully determined by the total number of proteins in the system and 
the box geometry, since as shown in Fig. 2, scaffold condensates can reach any droplet size when surfactants are 
absent. At low surfactant concentrations (i.e., % surfactant < 27.5% ), the maximum droplet size corresponds 
to a surface/volume ratio of ∼ 0.11 σ−1 . Beyond that threshold concentration, the condensate shrinks, and to 
achieve the equilibrium surface/volume ratio, it splits into smaller coexisting droplets. The maximum equilib-
rium droplet size in the two-droplet regime is that corresponding to ratios of ∼ 0.19 σ−1 . Finally, for surfactant 
compositions higher than 38% , three coexisting condensates emerge. The maximum surface/volume ratio that 
droplets can achieve is ∼ 0.27 σ−1 at 60% client composition, which is only possible due to the extreme reduc-
tion in the surface tension ( γ = 0.15 kBT σ−2)—more than one order of magnitude lower than that of the pure 
scaffold condensate ( γ = 1.58 kBT σ−2 ) at the same temperature and system density.
Previous studies have highlighted the challenges associated with measuring condensate surface tensions due 
to the small size of protein  droplets3, 87. Nonetheless, there are available estimates of this magnitude for ribonu-
cleoprotein condensates, and these measurements demonstrate that surfactant proteins can reduce γ by orders 
of  magnitude26. With our minimal model, we qualitatively observe such behavior when surfactant proteins are 
recruited to the condensate, giving rise to emulsions of multiple coexisting droplets with very low surface tension. 
Surfactant proteins can lead to the formation of multidroplet emulsions by inducing multilayered condensate 
 architectures26, 38. Diverse biomolecular organelles, either in the cell nucleus, such as the  nucleoli26, or nuclear 
 speckles77, as well as in the cytosol, such as stress granules,75, 76 exhibit this type of organization. Moreover, dif-
ferent in vitro complex  coacervates38, 50, 73, 74, bioengineered ribonucleoprotein condensates in living  cells88 and 
mixtures of RNA-binding proteins and RNA  molecules78, 79 are also known to show multilayered assemblies. In 
Fig. 4a, we analyze the droplet architecture of a protein condensate with a 50:50 scaffold–surfactant composition 
Table 2.  Properties of systems presented in Fig. 2 containing 50:50 scaffold–surfactant compositions in 
different simulation box geometries. In all cases, 6 independent simulations (with different initial velocity 
distributions), each starting from a pre-equilibrated configuration, were performed. For the geometries with 
more than one droplet, the values are averaged over the different droplets, although the variance between 
distinct droplets is significantly small as shown in Fig. 2 (Bottom panels).
Box geometry (a), 1 droplet (b), 2 droplets (c), 3 droplets
γ/(kBT/σ 2) 0.26(4) 0.23(4) 0.23(4)
Scaffold molar fraction in condensate 0.585(5) 0.576(5) 0.583(5)
Scaffold molar fraction in diluted phase 0.041(2) 0.041(2) 0.043(2)
ρ∗condensate 0.47(1) 0.47(1) 0.46(1)
ρ∗diluted phase 0.030(3) 0.027(3) 0.029(3)
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[i.e., the system in Fig. 2a (Middle panel)]. We find that in the droplet core, the scaffold to surfactant ratio is 
much higher than along the interfacial region (Fig. 4a), where it drops to almost half that of the surfactant pro-
teins. Nonetheless, the surfactant concentration within the droplet core is still remarkably high considering its 
destabilizing role in the condensate liquid network  connectivity49. The observed non-homogeneous condensate 
organization stems from the higher valency of scaffold proteins, which allows them to establish higher molecular 
connectivity within the core condensate and, thus, induce higher enthalpic gain upon multilayered assembly.
Finally, to gain further insight on the droplet liquid network connectivity, we evaluate the average number 
of engaged binding sites per protein ( ϕ ) as a function of distance from the center of mass of the condensates 
(Fig. 4b). Scaffold proteins present a significantly higher amount of molecular connections per protein than sur-
factants (i.e., ϕ ∼ 3.7 and ϕ ∼ 2.5 for scaffolds and surfactants, respectively), at the droplet core. This observation 
highlights how surfactants negatively contribute to the stability of the condensate. However at the interface, such 
diminished connectivity of surfactant proteins ( ϕ ∼ 1 ) with respect to that of scaffolds ( ϕ ∼ 3 ) substantially 
reduces the condensate surface tension—by decreasing the enthalpic cost ( hi ) of creating an interface. This 
energetically favorable protein arrangement, controlled in our model just by the variance in protein valency of 
the components, is expected to be contributed also by changes in relative binding affinities among proteins, and 
Figure 3.  Surface tension ( γ ) dependence on the scaffold–surfactant composition (in % ) at T∗/T∗c = 0.75 and 
system (global) density of ρ∗ = 0.136 . Vertical dashed lines indicate the maximum surfactant concentration 
which allows LLPS for a given number-droplet regime in our system. Note that the maximum droplet size 
varies continuously with surfactant concentration even within the same number-droplet regime. The maximum 
condensate size in terms of surface/volume ratio along the different number-droplet regimes are: ∼ 0.11 σ−1 
for the one-droplet regime, ∼ 0.19 σ−1 for the two-droplet regime, and ∼ 0.27 σ−1 for the three-droplet 
regime. At surfactant client compositions exceeding 65% there is no LLPS. For each computed composition, 
the global density of the system and the simulation box cross-section ( LzLy ) are kept constant. Snapshots of 
the DC simulations along different surfactant composition droplet regimes are included. Please note that in 
the multidroplet regime, the different coexisting droplets (at the same surfactant concentration) exhibit similar 
compositions and densities.
Figure 4.  (a) Droplet density profile (in reduced units) for scaffold (blue) and surfactant proteins (red) from 
the droplet center of mass towards the surrounding diluted phase for the 50:50 binary mixture within the 
simulation box geometry shown in Fig. 2a at T∗/T∗c = 0.75 . (b) Average number of engaged binding sites per 
protein ( ϕ ) as a function of distance from the droplet center of mass for scaffold (blue) and surfactant proteins 
(red). One binding site is considered to be engaged to another if the distance between them is less than 0.145 σ 
(i.e., the maximum bond length interaction between distinct protein binding sites; for further details on these 
calculations see Supporting Information).
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be modulated by post-translational modifications in vivo7, 34. Furthermore, such variations can be also relevant to 
understand the physical parameters controlling multilayered condensate organization and, ultimately, regulation 
of the formation of size-conserved multidroplet  emulsions29–31.
Conclusions
In this work, we employ our minimal protein  model48 to demonstrate how biomolecular multidroplet emulsifica-
tion can be controlled by the subtle balance between liquid network connectivity and droplet surface tension, and 
how general molecular features such as protein valency and binding affinity can critically regulate this behavior. 
By using a binary mixture of scaffold and client proteins that act as surfactants (following the original definition 
proposed by Banani et al.20), we design a set of Direct Coexistence simulations in which we can conveniently 
modulate the simulation box geometry to assess the propensity of the condensates to accommodate different sur-
face/volume ratios. The ability (or disability) of these mixtures to adopt different surface/volume ratios, imposed 
by the box geometry, can be regarded as an indirect measurement of the droplet propensity to grow beyond 
a certain size. We find that pure component scaffold condensates can easily adapt to distinct surface/volume 
ratios; in support of their ability to grow and fuse into a single droplet. However, 50:50 binary scaffold–surfactant 
mixtures stabilize instead several coexisting liquid condensates with roughly constant surface/volume ratios to 
accommodate the imposed system size geometry. Such behavior is a clear signature of size-conserved multidro-
plet emulsification, as found in the  nucleolus7, ribonucleoprotein  condensates26, 88, micelle-like  condensates31, 
45, and in vitro complex  coacervates38.
We also elucidate the role of surfactant concentration in size-conserved droplet growth. By gradually decreas-
ing the scaffold–surfactant ratio in our mixtures, we observe that the maximum droplet size is reduced, while 
simultaneously increasing the number of coexisting condensates. This trend continues until a sufficiently high 
surfactant concentration is reached, where LLPS is no longer possible. Moreover, as clients are added, the droplet 
surface tension dramatically decreases, facilitating the formation of multiple coexisting small liquid droplets at 
low interfacial energetic cost. Client proteins, besides decreasing the stability of the  condensates49, can effec-
tively behave as natural droplet  surfactants35, 36. Due to their considerably lower molecular connectivity com-
pared to that of scaffolds, surfactants preferentially migrate towards the droplet interface; thereby, minimizing 
the enthalpic cost of creating an  interface23. Heterogeneous molecular organizations of condensates have been 
observed in stress  granules75, 76, the  nucleoli26 and nuclear  speckles77. We find that such heterogeneity enable 
the maximization of the condensate liquid network connectivity through scaffold–scaffold protein interactions 
within the droplet core.
Rationalizing the underlying mechanisms employed by cells to precisely regulate the size of their diverse 
membraneless compartments and processing  bodies7, 34, 36 represents a crucial step towards understanding intra-
cellular spatiotemporal cell organization. Taken together, our coarse-grained simulations help to elucidate the 
relationship between single-droplet phase formation and size-conserved multidroplet architecture, and put for-
ward general molecular features such as valency and binding affinity as chief drivers in these scenarios.
Methods
We model our coarse-grained multivalent proteins using the MD-Patchy potential proposed in Ref.48, which is 
composed by two different set of potentials: a Pseudo Hard-Sphere (PHS)  potential89 to continuously describe 
the repulsive interaction and excluded volume between different protein replicas, and a continuous square-well 
(CSW)90 potential to describe the patch-patch interactions among different protein binding sites. The uPHS 
potential is described by the following expression:
where a = 49 and r = 50 are the exponents of the attractive and repulsive terms respectively, εR accounts for 
the energy shift of the PHS interaction, σ is the molecular diameter (and our unit of length) and r is the center-to-
center distance between different PHS particles. For the patch–patch interaction we use the following expression:
where εCSW is the depth of the potential energy well, rw the radius of the attractive well, and α controls the 
steepness of the well. We choose α = 0.005σ and rw = 0.12σ so that each patch can only interact with another 
single patch.
The mass of each patch is a 5% of the central PHS particle mass, which is set to 3.32× 10−26 kg, despite being 
this choice irrelevant for equilibrium simulations. This 5% ratio fixes the moment of inertia of the patchy particles 
(our minimal proteins). The molecular diameter of the proteins, both scaffold and clients, is σ = 0.3405 nm, 
and the value of εR/kB is 119.81K. All our results are presented in reduced units: reduced temperature is defined 
as T∗ = kBT/εCSW , reduced density as ρ∗ = (N/V)σ 3 , reduced pressure as p∗ = pσ 3/(kBT) , and the reduced 
unit of time as 
√
σ 2m/(kBT) . In order to keep the PHS interaction as similar as possible to a pure HS interac-
tion, we fix kBT/εR at a value of 1.5 as suggested in Ref.89 (fixing T = 179.71K). We then control the effective 
strength of the binding protein attraction by varying εCSW such that the reduced temperature, T∗ = kBT/εCSW , 
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Since both uPHS and uCSW potentials are continuous and differentiable, we perform all our simulations using 
the LAMMPS Molecular Dynamics  package91. Periodic boundary conditions are used in the three directions of 
space. The timestep chosen for the Verlet integration of the equations of motion is t∗ = 3.7× 10−4 . The cut-off 
radius of the interactions of both potentials is set to 1.17σ . We use a Nosé–Hoover  thermostat92, 93 for the NVT 
simulations with a relaxation time of 0.074 in reduced units. For NpT simulations, a Nosé–Hoover barostat is 
employed with the same relaxation  time94.
The methodological details of the calculation of the phase diagram, surface tension and engaged binding sites 
per protein through a local order parameter, are provided in the Supporting Information document.
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